First Manhattan CO. LLC. purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 9,837 shares of the financial services provider's stock, valued at approximately $367,000.
Several other hedge funds have also recently added to or reduced their stakes in TRUP. Raymond James Financial Inc. bought a new position in Trupanion during the 4th quarter worth approximately $593,000. Dimensional Fund Advisors LP grew its position in shares of Trupanion by 112.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after buying an additional 144,828 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Trupanion by 20.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,974 shares of the financial services provider's stock worth $626,000 after buying an additional 2,202 shares during the period. Voya Investment Management LLC grew its position in shares of Trupanion by 16.2% during the 4th quarter. Voya Investment Management LLC now owns 12,484 shares of the financial services provider's stock worth $602,000 after buying an additional 1,745 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in shares of Trupanion by 6.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 16,637 shares of the financial services provider's stock worth $802,000 after buying an additional 962 shares during the period.
Trupanion Stock Performance
NASDAQ TRUP opened at $44.18 on Thursday. The company has a fifty day simple moving average of $49.45 and a 200 day simple moving average of $44.02. Trupanion, Inc. has a 12-month low of $31.00 and a 12-month high of $57.90. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The company has a market cap of $1.90 billion, a P/E ratio of 169.93 and a beta of 1.72.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The business had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same quarter last year, the firm posted ($0.14) EPS. Trupanion's revenue was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on TRUP. Piper Sandler raised their price objective on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Stifel Nicolaus raised their price objective on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Finally, Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $54.17.
Read Our Latest Stock Analysis on Trupanion
Insider Transactions at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 2,800 shares of Trupanion stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the transaction, the chief financial officer directly owned 6,451 shares of the company's stock, valued at $293,907.56. The trade was a 30.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.42% of the stock is owned by corporate insiders.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.